Adam Brufsky, MD, PhD
Enriched profileProfessor of Medicine; Associate Division Chief, Division of Hematology/Oncology, University of Pittsburgh School of Medicine · University of Pittsburgh School of Medicine
Adam Brufsky is Professor of Medicine; Associate Division Chief, Division of Hematology/Oncology, University of Pittsburgh School of Medicine at University of Pittsburgh School of Medicine. OpenAlex indexes 1,001 publications with 37,097 citations (h-index 95); ClinicalTrials.gov lists 5 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Adam M. Brufsky, md, is Professor of Medicine at University of Pittsburgh School of Medicine / UPMC Hillman Cancer Center. The public record shows 1,001 publications with 37,097 citations (h-index 95), centered on Advanced Breast Cancer Therapies, Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 38 companies, 5 NIH-funded awards (1996–2026).
- Most recent indexed publication: 2026 · JCO precision oncology
- Top research focus: Advanced Breast Cancer Therapies
- 5 registered trials on ClinicalTrials.gov
- Open Payments reporting from 38 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 58 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 355.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:
- Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Sponsor: SWOG Cancer Research Network
- Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers
Sponsor: Vanderbilt-Ingram Cancer Center
- Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Sponsor: National Cancer Institute (NCI)
Industry payments
Updated 27 Aug 2026
38 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Gilead Sciences, Inc.Program year202557 payments$95,760openpaymentsdata.cms.gov ↗
- PFIZER INC.Program year202517 payments$39,511openpaymentsdata.cms.gov ↗
- Lilly USA, LLCProgram year202513 payments$33,573openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
81.3%Aromatase Inhibitor62.5%Anastrozole62%Letrozole29%Exemestane10%Part D≥109 patientsEstrogen Agonist/Antagonist9.5%Tamoxifen Citrate100%Part D≥27 patientsMetabolism & gastrointestinal
8.8%Serotonin-3 Receptor Antagonist5.4%Ondansetron Hcl60%Ondansetron Odt40%Part D<11 patientsCorticosteroid2.3%Prednisone100%Part D≥12 patientsNervous system
6.1%Phenothiazine4.4%Prochlorperazine Maleate100%Part D≥14 patientsGabapentinoids1.7%Gabapentin100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
5 NIH research awards on record, funded 1996–2026 per NIH RePORTER. The latest:
- NCI NCTN-Network Lead Academic Participating Site at UPMC Hillman Cancer Center
University of Pittsburgh at Pittsburgh
FY2026$1,032,700UG1CA233184 - NCI NCTN-Network Lead Academic Participating Site at UPMC Hillman Cancer Center
University of Pittsburgh at Pittsburgh
FY2025$865,242UG1CA233184
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
Most-cited works
by citation count (OpenAlex)- 01Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer2,370 citations2018
- 02Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer1,551 citations2021
- 03Prospective Validation of a 21-Gene Expression Assay in Breast Cancer1,440 citations2015
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/adam-brufsky-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - Google Scholar
scholar.google.com/citations
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholar.google.com ↗ - ResearchGate
researchgate.net/profile/Adam-Brufsky
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Instagram
instagram.com/p/DR8_b1liNeS
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →instagram.com ↗ - Instagram
instagram.com/reel/DPOkqGckZOu
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗ - Other
themedicinementors.libsyn.com/going-further-together-with-dr-adam-brufsky
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →themedicinementors.libsyn.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →people.dom.pitt.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →people.dom.pitt.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.upmc.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.upmc.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →people.dom.pitt.edu ↗
- Board Certification
Internal Medicine, American Board of Internal Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.upmc.com ↗ - Board Certification
Medical Oncology, American Board of Internal Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.upmc.com ↗
Editorial & leadership roles
journal and society appointments- Medical Director
Magee-Women's Cancer Program, UPMC Hillman Cancer Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.upmc.com ↗ - Associate Director for Clinical Investigations
UPMC Hillman Cancer Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.upmc.com ↗ - Co-Director
Comprehensive Breast Cancer Center, UPMC
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.upmc.com ↗
Awards & honors
honors on the public record- America's Top Doctors / Top Doctors for Cancer (Castle Connolly)
2005-present, including Pittsburgh Magazine Top Doctors 2025
2025verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pittsburghmagazine.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →people.dom.pitt.edu ↗
- Merrill J. Egorin Excellence in Scientific Leadership Award
University of Pittsburgh Cancer Institute
2011verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →people.dom.pitt.edu ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pittsburghmagazine.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pittsburghmagazine.com ↗
- Former Associate Physician and Instructor in Medicine
Harvard Medical School
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →upmc.com ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗
- Recurring expert commentator for AJMC (American Journal of Managed Care)
including "Invest in Human Capital to Improve Breast Cancer Care Delays" and "Postpandemic Breast Cancer Screening Rates Explained"
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ajmc.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Paul Palevsky, MD
University of Pittsburgh School of Medicine
Daniel Kaplan, MD, PhD
University of Pittsburgh School of Medicine
Samir Saba, MD
University of Pittsburgh School of Medicine
Deepak Sarpal, MD
University of Pittsburgh School of Medicine